Login Join for free
Popular Searches
Popular news More >
SEARCHING....
no results found
  • Real Time Chart Real Time Chart
  • Stock Profile Stock Profile

  • Financials As Reported

    • accession Number 0001599298-23-000054
    • accounts Payable Current 710,000
    • accounts Receivable Net Current 0
    • accumulated Other Comprehensive Income Loss Net Of Tax --1,396,000
    • allocated Share Based Compensation Expense 2,775,000
    • amendment Flag false
    • assets 254,897,000
    • assets Current 248,027,000
    • cash And Cash Equivalents At Carrying Value 70,969,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 70,969,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --577,638,000
    • cik 1,599,298
    • city Area Code 650
    • common Stock Par Or Stated Value Per Share 0.01
    • common Stock Shares Authorized 1,000,000,000
    • common Stock Shares Issued 697,685,365
    • common Stock Shares Outstanding 697,685,365
    • comprehensive Income Net Of Tax --541,878,000
    • contract With Customer Liability 0
    • contract With Customer Liability Current 0
    • current Fiscal Year End Date --12-31
    • date Filed 2023-05-11
    • depreciation 90,000
    • document Fiscal Period Focus Q1
    • document Fiscal Year Focus 2,023
    • document Period End Date 2023-03-31
    • document Transition Report false
    • document Type 10-Q
    • earnings Per Share Basic -1.43
    • earnings Per Share Diluted -1.43
    • entity Address Address Line 1 2882 Sand Hill Road, Suite 106
    • entity Address City Or Town Menlo Park
    • entity Address Postal Zip Code 94,025
    • entity Address State Or Province CA
    • entity Central Index Key 1,599,298
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 001-36866
    • entity Filer Category Non-accelerated Filer
    • entity Incorporation State Country Code DE
    • entity Interactive Data Current Yes
    • entity Name Summit Therapeutics Inc.
    • entity Registrant Name Summit Therapeutics Inc.
    • entity Shell Company false
    • entity Small Business true
    • entity Tax Identification Number 37-1979717
    • increase Decrease In Accounts Payable 308,000
    • increase Decrease In Accounts Receivable --350,000
    • increase Decrease In Contract With Customer Liability 0
    • increase Decrease In Other Operating Assets --508,000
    • interest Expense 8,327,000
    • interest Paid Net 1,306,000
    • irs Number 0
    • liabilities 121,415,000
    • liabilities And Stockholders Equity 254,897,000
    • liabilities Current 17,443,000
    • local Phone Number 460-8308
    • net Cash Provided By Used In Financing Activities 80,112,000
    • net Cash Provided By Used In Investing Activities --645,063,000
    • net Cash Provided By Used In Operating Activities --13,131,000
    • net Income Loss --542,376,000
    • noncurrent Assets 4,341,000
    • nonoperating Income Expense --5,222,000
    • operating Expenses 537,738,000
    • operating Income Loss --537,154,000
    • operating Lease Cost 346,000
    • operating Lease Liability Current 1,693,000
    • operating Lease Liability Noncurrent 2,491,000
    • operating Lease Payments 367,000
    • operating Lease Right Of Use Asset 3,928,000
    • other Assets Current 409,000
    • other Assets Noncurrent 156,000
    • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent 497,000
    • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 968,000
    • other Liabilities Current 320,000
    • other Liabilities Noncurrent 1,481,000
    • other Nonoperating Income Expense 417,000
    • payments To Acquire Property Plant And Equipment 53,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • property Plant And Equipment Net 412,000
    • report Link https://www.sec.gov/Archives/edgar/data/1599298/000159929823000054/smmt-20230331_htm.xml
    • research And Development Expense 9,883,000
    • retained Earnings Accumulated Deficit --920,706,000
    • revenue From Contract With Customer Excluding Assessed Tax 0
    • share Based Compensation 2,775,000
    • stockholders Equity 133,482,000
    • trading Symbol SMMT
    • update 1970-01-01
    • variable Lease Cost 43,000
    • weighted Average Number Of Diluted Shares Outstanding 378,163,980
    • weighted Average Number Of Shares Outstanding Basic 378,163,980
    • id REPORTED_FINANCIALS
    • key SMMT
    • subkey 10-Q
    • date 2023-05-11
    • updated 2023-05-12
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

SMMT stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001599298-23-000054
  • accounts Payable Current 710,000
  • accounts Receivable Net Current 0
  • accumulated Other Comprehensive Income Loss Net Of Tax --1,396,000
  • allocated Share Based Compensation Expense 2,775,000
  • amendment Flag false
  • assets 254,897,000
  • assets Current 248,027,000
  • cash And Cash Equivalents At Carrying Value 70,969,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 70,969,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --577,638,000
  • cik 1,599,298
  • city Area Code 650
  • common Stock Par Or Stated Value Per Share 0.01
  • common Stock Shares Authorized 1,000,000,000
  • common Stock Shares Issued 697,685,365
  • common Stock Shares Outstanding 697,685,365
  • comprehensive Income Net Of Tax --541,878,000
  • contract With Customer Liability 0
  • contract With Customer Liability Current 0
  • current Fiscal Year End Date --12-31
  • date Filed 2023-05-11
  • depreciation 90,000
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic -1.43
  • earnings Per Share Diluted -1.43
  • entity Address Address Line 1 2882 Sand Hill Road, Suite 106
  • entity Address City Or Town Menlo Park
  • entity Address Postal Zip Code 94,025
  • entity Address State Or Province CA
  • entity Central Index Key 1,599,298
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 001-36866
  • entity Filer Category Non-accelerated Filer
  • entity Incorporation State Country Code DE
  • entity Interactive Data Current Yes
  • entity Name Summit Therapeutics Inc.
  • entity Registrant Name Summit Therapeutics Inc.
  • entity Shell Company false
  • entity Small Business true
  • entity Tax Identification Number 37-1979717
  • increase Decrease In Accounts Payable 308,000
  • increase Decrease In Accounts Receivable --350,000
  • increase Decrease In Contract With Customer Liability 0
  • increase Decrease In Other Operating Assets --508,000
  • interest Expense 8,327,000
  • interest Paid Net 1,306,000
  • irs Number 0
  • liabilities 121,415,000
  • liabilities And Stockholders Equity 254,897,000
  • liabilities Current 17,443,000
  • local Phone Number 460-8308
  • net Cash Provided By Used In Financing Activities 80,112,000
  • net Cash Provided By Used In Investing Activities --645,063,000
  • net Cash Provided By Used In Operating Activities --13,131,000
  • net Income Loss --542,376,000
  • noncurrent Assets 4,341,000
  • nonoperating Income Expense --5,222,000
  • operating Expenses 537,738,000
  • operating Income Loss --537,154,000
  • operating Lease Cost 346,000
  • operating Lease Liability Current 1,693,000
  • operating Lease Liability Noncurrent 2,491,000
  • operating Lease Payments 367,000
  • operating Lease Right Of Use Asset 3,928,000
  • other Assets Current 409,000
  • other Assets Noncurrent 156,000
  • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent 497,000
  • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 968,000
  • other Liabilities Current 320,000
  • other Liabilities Noncurrent 1,481,000
  • other Nonoperating Income Expense 417,000
  • payments To Acquire Property Plant And Equipment 53,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • property Plant And Equipment Net 412,000
  • report Link https://www.sec.gov/Archives/edgar/data/1599298/000159929823000054/smmt-20230331_htm.xml
  • research And Development Expense 9,883,000
  • retained Earnings Accumulated Deficit --920,706,000
  • revenue From Contract With Customer Excluding Assessed Tax 0
  • share Based Compensation 2,775,000
  • stockholders Equity 133,482,000
  • trading Symbol SMMT
  • update 1970-01-01
  • variable Lease Cost 43,000
  • weighted Average Number Of Diluted Shares Outstanding 378,163,980
  • weighted Average Number Of Shares Outstanding Basic 378,163,980
  • id REPORTED_FINANCIALS
  • key SMMT
  • subkey 10-Q
  • date 2023-05-11
  • updated 2023-05-12

Related News

Iovance IOVA Rips to $13.64 on a $55M Guidance Raise as Amtagvi Runs 40% Quarter Over Quarter

Iovance IOVA Rips to $13.64 on a $55M Guidance Raise as Amtagvi Runs 40% Quarter Over Quarter

Itai Smidt 29.09.26
Stocks IOVA ASND SMMT EXEL
ORCL at $132.60 Trades at 16.4x Forward Earnings for 34% Revenue Growth as the Credit Market Prices Oracle at 90 Cents

ORCL at $132.60 Trades at 16.4x Forward Earnings for 34% Revenue Growth as the Credit Market Prices Oracle at 90 Cents

Itai Smidt 29.09.26
Stocks ORCL MSFT CRM NOW
Dow Slips to 51,385, S&P 500 Flat at 7,681, Nasdaq 26,826 as Fair Isaac FICO Craters 21.6% and Carnival CCL Surges 11.8%

Dow Slips to 51,385, S&P 500 Flat at 7,681, Nasdaq 26,826 as Fair Isaac FICO Craters 21.6% and Carnival CCL Surges 11.8%

Itai Smidt 29.09.26
Stocks Markets CCL FICO IOVA BE
VOO ETF at $705 as Record $13B Weekly Inflows Absorb the Rate Shock — $700 Floor Guards the Path to a New High

VOO ETF at $705 as Record $13B Weekly Inflows Absorb the Rate Shock — $700 Floor Guards the Path to a New High

Itai Smidt 28.09.26
Stocks Markets NVDA AAPL MSFT AMZN
KOD Surges Toward $90 as Zenkuda Hits p=0.0007 With a Majority on 24-Week Dosing — Q4 BLA and December PEAK Data Next

KOD Surges Toward $90 as Zenkuda Hits p=0.0007 With a Majority on 24-Week Dosing — Q4 BLA and December PEAK Data Next

Itai Smidt 28.09.26
Stocks KOD SYRE OCUL EYPT
META Pulls Back From $779 as Muse Tops 3.4M Downloads

META Pulls Back From $779 as Muse Tops 3.4M Downloads

Itai Smidt 28.09.26
Stocks META PINS SNAP RDDT
Trade Now
© Trading News. All Rights Reserved Since 2022